TUBA1A
MOLECULAR TARGETtubulin alpha 1a
TUBA1A (tubulin alpha 1a) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TUBA1A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Colchicine | 4.86 | 128 |
| 2 | Nocodazole Nocodazole is | 3.43 | 30 |
| 3 | Podophyllotoxin | 2.94 | 18 |
| 4 | Vincristine | 2.48 | 11 |
| 5 | Demecolcine | 0.69 | 1 |
| 6 | Maytansine | 0.69 | 1 |
| 7 | Noscapine | 0.69 | 1 |
| 8 | vinblastine sulfate | 0.69 | 1 |
| 9 | Vorinostat | 0.69 | 1 |
About TUBA1A as a Drug Target
TUBA1A (tubulin alpha 1a) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBA1A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TUBA1A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.